Aurélie Olivier
GlaxoSmithKline (Belgium)(BE)
Publications by Year
Research Areas
Respiratory viral infections research, Malaria Research and Control, Pneumonia and Respiratory Infections, Tracheal and airway disorders, Inflammation biomarkers and pathways
Most-Cited Works
- → Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons(2024)142 cited
- → Nangibotide in patients with septic shock: a Phase 2a randomized controlled clinical trial(2020)70 cited
- → T Cell Responses to the RTS,S/AS01E and RTS,S/AS02D Malaria Candidate Vaccines Administered According to Different Schedules to Ghanaian Children(2011)65 cited
- → TLR3 ligand stimulates fully functional memory CD8+ T cells in the absence of CD4+ T-cell help(2007)62 cited
- → The Notch ligand delta-1 is a hematopoietic development cofactor for plasmacytoid dendritic cells(2005)57 cited
- → Variation in morphology and performance of predator-sensing system in wild cricket populations(2005)56 cited
- → Induction of Plasmodium falciparum-Specific CD4+ T Cells and Memory B Cells in Gabonese Children Vaccinated with RTS,S/AS01E and RTS,S/AS02D(2011)50 cited
- → A Partial Down-regulation of WASP Is Sufficient to Inhibit Podosome Formation in Dendritic Cells(2005)49 cited
- → Respiratory Syncytial Virus Prefusion F Protein Vaccine Is Efficacious in Older Adults With Underlying Medical Conditions(2023)48 cited
- → Role ofrsbUand Staphyloxanthin in Phagocytosis and Intracellular Growth ofStaphylococcus aureusin Human Macrophages and Endothelial Cells(2009)46 cited